These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29619854)

  • 1. Tf ligand-receptor-mediated exenatide-Zn
    Zhang L; Shi Y; Song Y; Duan D; Zhang X; Sun K; Li Y
    J Drug Target; 2018 Dec; 26(10):931-940. PubMed ID: 29619854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of low molecular weight protamine to enhance oral absorption of exenatide.
    Zhang L; Shi Y; Song Y; Sun X; Zhang X; Sun K; Li Y
    Int J Pharm; 2018 Aug; 547(1-2):265-273. PubMed ID: 29800739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery system for low molecular weight protamine-dextran-poly(lactic-co-glycolic acid) carrying exenatide to overcome the mucus barrier and improve intestinal targeting efficiency.
    Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Zhang X; Sun K
    Nanomedicine (Lond); 2019 Apr; 14(8):989-1009. PubMed ID: 31088322
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
    Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
    Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice.
    Shi Y; Sun X; Zhang L; Sun K; Li K; Li Y; Zhang Q
    Sci Rep; 2018 Jan; 8(1):726. PubMed ID: 29335533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
    Nag M; Gajbhiye V; Kesharwani P; Jain NK
    Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
    Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
    Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide.
    Menzel C; Holzeisen T; Laffleur F; Zaichik S; Abdulkarim M; Gumbleton M; Bernkop-Schnürch A
    J Control Release; 2018 May; 277():165-172. PubMed ID: 29574041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
    Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
    Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of PLGA nanoparticles in yeast cell wall particle system for oral targeted delivery of exenatide to improve its hypoglycemic efficacy.
    Ren T; Zheng X; Bai R; Yang Y; Jian L
    Int J Pharm; 2021 May; 601():120583. PubMed ID: 33839225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
    Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
    J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X; Li J; Yan M
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice.
    Bao X; Qian K; Yao P
    J Nanobiotechnology; 2020 Apr; 18(1):67. PubMed ID: 32345323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics.
    Zhai J; Ou Z; Zhong L; Wang YE; Cao LP; Guan S
    Drug Deliv; 2020 Nov; 27(1):1667-1675. PubMed ID: 33241694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems.
    Bai Y; Zhou R; Wu L; Zheng Y; Liu X; Wu R; Li X; Huang Y
    J Mater Chem B; 2020 Apr; 8(13):2636-2649. PubMed ID: 32129375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
    Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
    Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on preparation and oral efficacy of insulin-loaded poly(lactic-co-glycolic acid) nanoparticles].
    Pan Y; Xu H; Zhao HY; Wei G; Zheng JM
    Yao Xue Xue Bao; 2002 May; 37(5):374-7. PubMed ID: 12579845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transferrin variant as the targeting ligand for polymeric nanoparticles incorporated in 3-D PLGA porous scaffolds.
    Lopes AM; Chen KY; Kamei DT
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():373-380. PubMed ID: 28183621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.